These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37274474)

  • 21. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.
    Wang JC; Hou JY; Chen JC; Xiang CL; Mao XH; Yang B; Li Q; Liu QB; Chen J; Ye ZW; Peng W; Sun XQ; Chen MS; Zhou QF; Zhang YJ
    Eur J Cancer; 2021 Sep; 155():85-96. PubMed ID: 34371445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging.
    Li Q; Wei Y; Zhang T; Che F; Yao S; Wang C; Shi D; Tang H; Song B
    Insights Imaging; 2023 Jan; 14(1):4. PubMed ID: 36617581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection.
    Huang Y; Chen H; Zeng Y; Liu Z; Ma H; Liu J
    Front Oncol; 2020; 10():593741. PubMed ID: 33598425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma.
    Xie GL; Liang L; Ye TW; Xu FQ; Wang DD; Xie YM; Zhang KJ; Fu TW; Yao WF; Liu JW; Zhang CW
    Front Oncol; 2023; 13():1089716. PubMed ID: 37124507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
    Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study.
    Huang Q; Chen Y; Lin K; Sun C; Zheng S; Chen J; Wang Y; Zhou Y; Zhou W; Liu J; Zeng Y
    Front Oncol; 2021; 11():673285. PubMed ID: 34722235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy.
    Ma C; Cao Y; Zhang G; Qiu J; Zhou Y; Wang P; Wang S; Yan D; Ma D; Jiang C; Wang Z
    J Hepatocell Carcinoma; 2023; 10():217-230. PubMed ID: 36798739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery.
    Shao G; Ma Y; Qu C; Gao R; Zhu C; Qu L; Liu K; Li N; Sun P; Cao J
    J Hepatocell Carcinoma; 2024; 11():679-691. PubMed ID: 38585292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma-A Multicentre Experience.
    Zheng Z; Guan R; Zou Y; Jian Z; Lin Y; Guo R; Jin H
    J Inflamm Res; 2022; 15():5089-5102. PubMed ID: 36091335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection.
    Lee IC; Huang JY; Chen TC; Yen CH; Chiu NC; Hwang HE; Huang JG; Liu CA; Chau GY; Lee RC; Hung YP; Chao Y; Ho SY; Huang YH
    Liver Cancer; 2021 Nov; 10(6):572-582. PubMed ID: 34950180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
    Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
    Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
    Ma E; Li J; Xing H; Li R; Shen C; Zhang Q; Ma Z; Tao Y; Qin L; Zhao J; Wang Z
    Ann Transl Med; 2021 Mar; 9(6):468. PubMed ID: 33850865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation and validation of machine learning models for preoperative estimation of microvascular invasion risk in hepatocellular carcinoma.
    Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Ding W; Wu J; Wang X
    Ann Transl Med; 2023 Mar; 11(6):249. PubMed ID: 37082689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.